Risks of electrocardiographic left ventricular hypertrophy in hypertensive individuals and benefits of treatment-induced regression Academic Article uri icon


MeSH Major

  • Autistic Disorder
  • Gene Regulatory Networks
  • Receptors, Metabotropic Glutamate


  • Left ventricular hypertrophy (LVH), a common complication of hypertension, is an important risk factor for cardiovascular disease. Patients with LVH are at a markedly increased risk for many cardiovascular complications and death. This heightened risk can be mitigated in part by antihypertensive therapy-induced regression of LVH. The electrocardiogram (ECG) is a valuable modality in the identification, risk stratification, and longitudinal follow-up of patients with hypertension and LVH. This article details the prognostic significance of ECG LVH and the benefits associated with treatment-induced LVH regression. © 2009 Current Medicine Group, LLC.

publication date

  • December 2009



  • Academic Article


Digital Object Identifier (DOI)

  • 10.1007/s12170-009-0039-2

Additional Document Info

start page

  • 247

end page

  • 254


  • 3


  • 4